SOFIA (Bulgaria), August 14 (SeeNews) – Bulgarian veterinary drug maker Biovet [BUL:53B] said on Wednesday its consolidated net profit rose 58% to 6.7 million levs ($4.5 million/3.4 million euro) in the first half of 2013.